Sponsor or institution
Clinical trials and research at Genrix (Shanghai) Biopharmaceutical Co., Ltd.
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Genrix (Shanghai) Biopharmaceutical Co., Ltd. that are recruiting, in China. By phase: Phase 3 (2), Phase 2 (1), Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| GR1803 injection versus daratumumab plus pomalidomide and dexamethasone for relapsed or refractory multiple myeloma | Phase 3 | Tianjin | Recruiting | Mar 5, 2026 |
| GR1803 for systemic lupus erythematosus (SLE) | Phase 1/2 | Wuhan, Hubei | Recruiting | Jan 16, 2026 |
| GR2303 injection safety and immune response in healthy adults | Phase 1 | Beijing, Beijing Municipality | Recruiting | Sep 30, 2025 |
| IL4Rα antibody for seasonal allergic rhinitis (hay fever) | Phase 3 | Wuhan, Hubei | Recruiting | Sep 4, 2025 |
| GR1803 injection for patients with relapsed/refractory multiple myeloma | Phase 2 | Tianjin, Tianjin Municipality | Recruiting | Apr 30, 2025 |
All recruiting trials (5)
-
GR1803 injection versus daratumumab plus pomalidomide and dexamethasone for relapsed or refractory multiple myeloma
This trial tests whether GR1803 injection works better than daratumumab combined with pomalidomide and dexamethasone for adults with relapsed or refractory multiple myeloma who have had one to three prior treatments.
-
GR1803 for systemic lupus erythematosus (SLE)
This trial will test GR1803 injections in people with active systemic lupus (SLE) to see if the drug is safe and helps control lupus symptoms.
-
GR2303 injection safety and immune response in healthy adults
This trial will try GR2303 injections in healthy adults to see if they are safe and how the body handles them and responds immunologically.
-
IL4Rα antibody for seasonal allergic rhinitis (hay fever)
This trial will test whether injections of an IL4Rα monoclonal antibody help people with seasonal allergic rhinitis (hay fever) who haven't been well controlled with nasal steroids.
-
GR1803 injection for patients with relapsed/refractory multiple myeloma
This study is testing if the GR1803 injection can help people with relapsed or refractory multiple myeloma feel better and manage their disease.
Quick answers
How many clinical trials run by Genrix (Shanghai) Biopharmaceutical Co., Ltd. are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 1, Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.